当前位置:首页 - 行情中心 - 特一药业(002728) - 财务分析 - 现金流量表

特一药业

(002728)

  

流通市值:49.17亿  总市值:66.95亿
流通股本:3.77亿   总股本:5.13亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金763,287,771.48570,257,085.16334,097,865.17620,668,084.11
  收到其他与经营活动有关的现金6,550,502.693,137,823.421,635,008.9611,969,937.96
  经营活动现金流入小计769,838,274.17573,394,908.58335,732,874.13632,638,022.07
  购买商品、接受劳务支付的现金183,726,560.5135,528,055.0871,047,116.44313,341,321.1
  支付给职工以及为职工支付的现金85,500,588.1757,316,77929,021,318.36102,862,034.01
  支付的各项税费58,972,603.0849,723,211.0135,549,031.762,565,865.32
  支付其他与经营活动有关的现金250,445,074.91184,620,532.13110,731,651.83176,418,555.2
  经营活动现金流出小计578,644,826.66427,188,577.22246,349,118.33655,187,775.63
  经营活动产生的现金流量净额191,193,447.51146,206,331.3689,383,755.8-22,549,753.56
二、投资活动产生的现金流量:
  取得投资收益收到的现金748,710.96299,726.03186,410.963,735,807.58
  处置固定资产、无形资产和其他长期资产收回的现金净额200,000200,000200,00023,480
  收到的其他与投资活动有关的现金185,000,000110,000,00090,000,000892,010,000
  投资活动现金流入小计185,948,710.96110,499,726.0390,386,410.96895,769,287.58
  购建固定资产、无形资产和其他长期资产支付的现金55,854,596.8837,445,391.9919,330,790.44113,557,403.72
  支付其他与投资活动有关的现金285,000,000185,000,000140,000,000892,010,000
  投资活动现金流出小计340,854,596.88222,445,391.99159,330,790.441,005,567,403.72
  投资活动产生的现金流量净额-154,905,885.92-111,945,665.96-68,944,379.48-109,798,116.14
三、筹资活动产生的现金流量:
  吸收投资收到的现金13,725,358.8611,086,308.4810,580,687.5213,877,365.54
  取得借款收到的现金420,000,000310,000,000160,000,0001,013,779,943.86
  收到其他与筹资活动有关的现金154,000,000154,000,000104,000,000530,000,000
  筹资活动现金流入小计587,725,358.86475,086,308.48274,580,687.521,557,657,309.4
  偿还债务支付的现金677,000,000517,000,000417,000,000809,000,000
  分配股利、利润或偿付利息支付的现金27,692,820.32,167,198.561,181,376.66182,307,116.95
  支付其他与筹资活动有关的现金37,336,006.477,336,006.4791,594.14677,856,250.88
  筹资活动现金流出小计742,028,826.77526,503,205.03418,272,970.81,669,163,367.83
  筹资活动产生的现金流量净额-154,303,467.91-51,416,896.55-143,692,283.28-111,506,058.43
五、现金及现金等价物净增加额-118,015,906.32-17,156,231.15-123,252,906.96-243,853,928.13
  加:期初现金及现金等价物余额302,961,723.49302,961,723.49302,961,723.49546,815,651.62
  期末现金及现金等价物余额184,945,817.17285,805,492.34179,708,816.53302,961,723.49
补充资料:
  净利润-38,007,729.88-20,495,003.39
  资产减值准备--2,302,376.77-12,235,985
  固定资产和投资性房地产折旧-28,268,607.64-51,755,137.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,268,607.64-51,755,137.99
  无形资产摊销-6,426,240.19-12,611,310.74
  长期待摊费用摊销---52,500.17
  处置固定资产、无形资产和其他长期资产的损失-83,374.88--2,078.21
  固定资产报废损失---163,055.68
  财务费用-3,073,825.93-5,299,835.17
  投资损失--299,726.03--3,735,807.58
  递延所得税-2,993,489.38--902,419.59
  其中:递延所得税资产减少-3,139,353.84--4,837,757.58
    递延所得税负债增加--145,864.46-3,935,337.99
  存货的减少--21,827,924.9-6,702,686.39
  经营性应收项目的减少-66,936,115.77--42,918,019.35
  经营性应付项目的增加-24,846,975.39--85,028,867.56
  其他---721,924.2
  现金的期末余额-285,805,492.34-302,961,723.49
  减:现金的期初余额-302,961,723.49-546,815,651.62
  现金及现金等价物的净增加额--17,156,231.15--243,853,928.13
公告日期2025-10-242025-08-222025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑